Literature DB >> 20708995

History of cancer and mortality in community-dwelling older adults.

Elizabeth Kvale1, O James Ekundayo, Yan Zhang, Shamima Akhter, Inmaculada Aban, Thomas E Love, Christine Ritchie, Ali Ahmed.   

Abstract

BACKGROUND: The association between a history of cancer and mortality has not been studied in a propensity-matched population of community-dwelling older adults.
METHODS: Of the 5795 participants in the Cardiovascular Health Study, 827 (14%) had self-reported physician-diagnosed cancer at baseline. Propensity scores for cancer were used to assemble a cohort of 789 and 3118 participants with and without cancer respectively who were balanced on 45 baseline characteristics. Cox regression models were used to determine the association between cancer and all-cause mortality among matched patients, and to identify independent predictors of mortality among unmatched cancer patients.
RESULTS: Matched participants had a mean (SD) age of 74 (6) years, 57% were women, 10% were African Americans, and 38% died from all causes during 12 years of follow-up. All-cause mortality occurred in 41% and 37% of matched participants with and without a history of cancer respectively (hazard ratio when cancer was compared with no cancer, 1.16; 95% confidence interval, 1.02-1.31; P=0.019). Among those with cancer, older age, male gender, smoking, lower than college education, fair-to-poor self-reported health, coronary artery disease, diabetes mellitus, chronic kidney disease, left ventricular hypertrophy, increased heart rate, low hemoglobin and low baseline albumin were associated with increased risk of mortality.
CONCLUSIONS: Among community-dwelling older adults, a history of cancer was associated with increased mortality and among those with cancer, several socio-demographic variables and morbidities predicted mortality. These findings suggest that addressing traditional risk factors for cardiovascular mortality may help improve outcomes in older adults with a history of cancer. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20708995      PMCID: PMC3062071          DOI: 10.1016/j.canep.2010.07.011

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  36 in total

1.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

Review 2.  Antineoplastic chemotherapy of the older cancer patient.

Authors:  L Balducci; M B Corcoran
Journal:  Hematol Oncol Clin North Am       Date:  2000-02       Impact factor: 3.722

3.  Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men.

Authors:  L Kilander; L Berglund; M Boberg; B Vessby; H Lithell
Journal:  Int J Epidemiol       Date:  2001-10       Impact factor: 7.196

Review 4.  Bleomycin-induced pneumonitis.

Authors:  S Sleijfer
Journal:  Chest       Date:  2001-08       Impact factor: 9.410

5.  Survival associated with two sets of diagnostic criteria for congestive heart failure.

Authors:  Gina D Schellenbaum; Thomas D Rea; Susan R Heckbert; Nicholas L Smith; Thomas Lumley; Veronique L Roger; Dalane W Kitzman; Herman A Taylor; Daniel Levy; Bruce M Psaty
Journal:  Am J Epidemiol       Date:  2004-10-01       Impact factor: 4.897

6.  Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.

Authors:  Matthew C Hull; Christopher G Morris; Carl J Pepine; Nancy Price Mendenhall
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

7.  Cancer in older persons: an international issue in an aging world.

Authors:  Rosemary Yancik; Lynn A G Ries
Journal:  Semin Oncol       Date:  2004-04       Impact factor: 4.929

8.  Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study.

Authors:  B M Psaty; C D Furberg; L H Kuller; N O Borhani; P M Rautaharju; D H O'Leary; D E Bild; J Robbins; L P Fried; C Reid
Journal:  JAMA       Date:  1992-09-09       Impact factor: 56.272

9.  Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

Authors:  L J Steinherz; P G Steinherz; C T Tan; G Heller; M L Murphy
Journal:  JAMA       Date:  1991-09-25       Impact factor: 56.272

10.  Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study.

Authors:  Mustafa I Ahmed; Wilbert S Aronow; Michael H Criqui; Inmaculada Aban; Thomas E Love; Eric J Eichhorn; Ali Ahmed
Journal:  Circ Heart Fail       Date:  2009-10-27       Impact factor: 8.790

View more
  4 in total

1.  Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment.

Authors:  O O Faluyi; S P Masinghe; R L Hayward; S Clive
Journal:  Med Oncol       Date:  2011-02-01       Impact factor: 3.064

2.  Relationship between stage of kidney disease and incident heart failure in older adults.

Authors:  C Barrett Bowling; Margaret A Feller; Marjan Mujib; Pushkar P Pawar; Yan Zhang; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Stefan D Anker; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Nephrol       Date:  2011-07-04       Impact factor: 3.754

3.  Intrinsic association of widowhood with mortality in community-dwelling older women and men: findings from a prospective propensity-matched population study.

Authors:  Beverly R Williams; Yan Zhang; Patricia Sawyer; Marjan Mujib; Linda G Jones; Margaret A Feller; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Amy Lott; Ali Ahmed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-09-07       Impact factor: 6.053

4.  Reducing tobacco-related cancer incidence and mortality: summary of an institute of medicine workshop.

Authors:  Erin P Balogh; Carolyn Dresler; Mark E Fleury; Ellen R Gritz; Thomas J Kean; Matthew L Myers; Sharyl J Nass; Brenda Nevidjon; Benjamin A Toll; Graham W Warren; Roy S Herbst
Journal:  Oncologist       Date:  2013-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.